Fleishman-Hillard to assist UCB in its Cimzia launch
September 14, 2007Medical Communications
UCB is preparing its Crohn's disease treatment, Cimzia, for a 2008 launch in Europe.This is the first of a number …
Pfizer closes Kent manufacturing base
September 14, 2007Manufacturing and Production
Pfizer will close its Sandwich, Kent manufacturing plant over the next two years with the loss of 420 jobs.It spells …
Resolute wins first global account
September 12, 2007Medical Communications Resolute
London-based PR agency Resolute has won its first global account since setting up its New York office earlier this year.The …
Boehringer bids for oncology presence with lung cancer treatment
September 10, 2007Sales and Marketing
A novel treatment for lung cancer which could help patients who develop resistance to other drugs is being developed by …
UK stem-cell research to benefit from hybrid embryos decision
September 10, 2007Research and Development stem cell
A new ruling on the use of hybrid human-animal embryos could help UK researchers extend their lead over European rivals.The …
How can customer insight work for you?
September 10, 2007Sales and Marketing customers, insight, sales
It should be a very simple equation: if you can understand what motivates clinicians – and all the other prescribing …
Latest news from Datamonitor
September 10, 2007Research and Development, Sales and Marketing
Akela reports positive results for Fentanyl Taifun trialAkela Pharma has reported promising results from a phase IIb trial for its …
New Tsar of Tsars appointed to lead clinical engagement
September 6, 2007A leading heart surgeon has been appointed to ensure frontline doctors are engaged with health service reform and ensure their …
Sanofi manager wins Cranfield scholarship
September 6, 2007Business Services careers
A scholarship to study for an MBA at the renowned Cranfield School of Management has been won by a pharmaceutical …
Merck Serono seeks first-line use for Erbitux
September 6, 2007Sales and Marketing Erbitux
Merck Serono has seeking a broader licence for its cancer drug Erbitux in Europe to include use as a first-line …
AZ opens clinical pharmacology unit in China
September 6, 2007Research and Development China, em
AstraZeneca has opened its first ever clinical pharmacology unit in China, providing support for more trials to be carried out …
NICE says yes to asthma treatment Xolair
September 6, 2007Sales and Marketing Xolair
Xolair, a drug which helps control the most severe cases of allergic asthma, has been approved for use on the …
European challenge to restrictions on Sutent prescribing
September 6, 2007The European Commission has been asked to intervene in a row over a patient's access to kidney cancer drug Sutent, …
Generic challenger to Eprex approved
September 6, 2007Sales and Marketing
The first ever biosimilar version of blockbuster anaemia drug epoetin alfa has been approved in Europe.The drug is marketed by …
Look who’s talking now
September 3, 2007Medical Communications, Sales and Marketing blog, digi pharma, digital pharma, new media, social networking, technology
The internet loves a good scandal. From compromising celebrity videos to the latest political whisperings, whatever your interest in life, …
Latest news from Datammonitor
August 31, 2007Sales and Marketing
Advanced Life Sciences metastatic melanoma drug granted orphan statusThe FDA has granted orphan drug designation to Advanced Life Sciences for …
GSK’s orphan drug for leukaemia approved
August 30, 2007Sales and Marketing
Atriance, a new treatment for two rare, but deadly, types of blood cancer has been approved in Europe as an …
New blood pressure drug Rasilez approved in Europe
August 30, 2007Sales and Marketing
New high blood pressure medication Rasilez has been approved in Europe, with its marketers Novartis claiming it is the first …
Efficient NHS will stay out of debt, says Johnson
August 30, 2007Health secretary Alan Johnson has confidently predicted that the NHS will not slip back into debt this year – and …
New Rebif formulation approved in Europe
August 30, 2007Sales and Marketing
A new version of multiple sclerosis treatment Rebif, which promises to produce fewer reactions when patients inject it, is to …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
